Hypothesis

Core claim: With advancing age, loss of autophagic flux in hepatocytes triggers a hypoxic‑stress response that elevates hepatic synthesis of coagulation Factor VIII, thereby contributing to the systemic prothrombotic phenotype of aging. Restoring autophagy normalizes HIF‑1α activity and reduces FVIII output.

Mechanistic rationale

• Autophagy normally removes damaged mitochondria, limiting mitochondrial ROS production. When autophagic flux falls (see PMC9835585), ROS accumulate and stabilize HIF‑1α even under normoxia.
• HIF‑1α binds hypoxia‑response elements in the F8 promoter, boosting transcription of Factor VIII mRNA. This links organelle quality control directly to clotting factor synthesis.
• Elevated plasma Factor VIII can activate thrombin generation; thrombin‑PAR1 signaling feeds back to stimulate mTORC1, which further suppresses autophagy (PubMed24853422), creating a vicious cycle.
• Young plasma reverses hepatic autophagy impairment in rats (DOI10.1111/acel.12708), suggesting that systemic factors can restore autophagic capacity and thereby lower HIF‑1α‑driven FVIII expression.
• Bone‑marrow‑derived secretory changes with autophagy loss (Aging-us203127) may amplify inflammation, but the hepatic axis provides a direct route to the coagulation cascade.

Testable predictions

1. Genetic loss – Liver‑specific Atg7 knockout in young mice will recapitulate the aged phenotype: ↑ hepatic HIF‑1α, ↑ plasma Factor VIII, shortened clotting times (aPTT) and heightened thrombin generation in calibrated automated thrombogram.
2. Pharmacological rescue – Treating aged mice with liver‑targeted spermidine nanoparticles will restore autophagic flux (LC3‑II/I ratio, p62 degradation), reduce hepatic HIF‑1α protein, normalize Factor VIII levels, and bring thrombin generation back to youthful baselines.
3. Mechanistic blockade – Inhibiting HIF‑1α with PX‑478 in aged Atg7‑deficient livers will lower Factor VIII without altering autophagy, demonstrating that the autophagy‑FVIII link is HIF‑1α dependent.
4. Human correlate – In older adults, peripheral blood mononuclear cell autophagic flux (measured by LC3 turnover ex vivo) will inversely correlate with plasma Factor VIII concentration after adjusting for age, inflammation, and liver function.

Falsifiability

If liver‑specific autophagy restoration fails to decrease Factor VIII or thrombin generation despite verified increase in autophagic markers, or if HIF‑1α inhibition does not affect Factor VIII levels, the hypothesis would be refuted. Conversely, a consistent inverse relationship between autophagic capacity and FVIII across models would support it.

Broader implication

Viewing autophagy as a rheostat that sets the cell’s “readiness” for stress reframes anti‑aging interventions: agents that boost autophagy may work not by generic “cleaning” but by re‑setting stress‑signaling pathways that erroneously drive pro‑coagulant programs.